- £1.09m
- -£0.37m
- £0.03m
First Sale of New Product Line
Directorate Change
Marketing Agreement
Brief: ValiRx H1 EPS GBP -0.007
Half-year Report
Brief: Valirx Says It Will Return Evaluation Project To University Of Barcelona Researchers For Further Development
Marketing Agreement
Inaphaea Evaluation and Commercial Use Agreement
Marketing Agreement
Brief: Valirx Says Unit Inaphaea Executes Agreement With DLOC Biosystems
Inaphaea Evaluation and Commercial Use Agreement
Brief: ValiRx Says Inaphaea Executes Agreement With Bioreperia
Brief: ValiRx Says Mark Eccleston Appointed CEO
Directorate Change
Brief: Valirx Plc Appoints Martin Gouldstone As Independent Non-Exec Chairman
Directorate Changes
Proposed Director Appointment
Directorate Change
Inaphaea Contract Award